On page 7:
DEA requests 124 positions, including 50 Special Agents, 50 Diversion Investigators, and 9 Intelligence Analysts, and $30,885,000 to support regulatory and enforcement activities of the Diversion Control Program. This request includes $9,393,000 in non-personnel funding for rent, task force officer overtime, administrative support, and training for Tactical Diversion Squads (TDS). These resources will support DEA’s efforts to fulfill both the regulatory control and enforcement aspects of the Diversion Control Program.
Expanded details for the budget on prescription drug enforcement begin on page 70. The reasons for the increased amounts sought are on page 78. The increases are broken down beginning on page 101.
The Department of Justice share of the 2011 drug budget takes up 34 pages. For its Organized Crime Drug Enforcement Task Force (OCDETF) Program, it got $579 million. By function: $362.7 million went to investigations, $168 million went to prosecutions and $48 million went to "intelligence." By agencies involved in OCDTEF, the DEA got $220 million, the FBI got $149 million and ATF, got $14 million. U.S. Attorneys (prosecutors) got $162 million. (This doesn't include the OCDTEF amounts for ICE, the IRS, or the Coast Guard, which are funded with direct appropriations of the Departments of Homeland Security and Treasury.)
The 2012 DOJ OCDTEF numbers are here.
More from Kerlikowske on the Obama approach is here.
As an aside, just how many DEA agents are there? From the 2012 budget justification:
DEA has approximately 6,000 sworn domestic law enforcement officers, of which 3,800 are onboard DEA special agents and 2,200 are cross-designated, state or local Task Force Officers (TFOs). These TFOs work full time with DEA and comprise more than one-third of DEA’s entire domestic investigative workforce.
Back to yesterday's hearing: Also testifying were Florida Governor Rick Scott, who is backtracking off his opposition to Florida's prescription database program and Kentucky's Governor Steve Beshear. Other witnesses included several parents of deceased children and spokespersons for pro-drug war organizations, one of which is channeling MADD: Mothers Against Prescription Drug Abuse.
Was anyone allowed to speak for pain patients? The lone voice opposing the crowd of drug warriors was Patrick Coyne, RN, MSN, Clinical Director,
Thomas Palliative Care Unit, Virginia Commonwealth University Medical Center on behalf of the Oncology Nursing Society. I recommend reading his testimony.
There are plenty of issues with this expanded war on pain medications and doctors. The prescription monitoring databases are huge civil liberties intrusions. The tactics used against so-called pill mills as well as pain doctors and even patients are straight out of the playbook of the War on Drugs:
- aggressive undercover investigation and undercover buys,
- asset forfeiture, take everything they have, cars, houses, office buildings, jewelry
- informants – bust the "addict" patients and squeeze until they give up the doctors
- oppose bail for doctors to increase quick plea deals
- get warrants for searches of doctors' offices and computers, patient records, bank records and residences. Leave no stone unturned.
- partner up with state law enforcement: share information and conduct joint investigations through the DEA Tactical Diversion Squads.
Here's some reading from the side not represented at yesterday's hearing: CATO Policy Analysis: Treating Doctors as Drug Dealers, The DEA’s War on Prescription Painkillers. Especially read the section on the DEA's flawed conclusions from available data on prescription drug-related deaths. And on law enforcement's fundamental misunderstanding of the differences between addiction, tolerance, and dependence. And on the erroneous statistics on risk of death associated with OxyContin.
Pain experts maintain that:
- Properly prescribed and used opioids rarely, if ever, lead to addiction.
there is no upper limit of safety for opioid dosages. "[A]s long as the dose is [started] low and increased gradually, large doses [may] be taken [and are] limited only by adverse [side] effects."
- Unlike non-opioid analgesics, opioids do not cause damage to major organs.
- Different patients require different amounts. The correct amount is what reduces or eliminates the patient's pain without unacceptable side effects.
[Added: on the distinctions between tolerance, physical dependence and addiction:]
Tolerance results when exposure to a drug leads to a reduction in one or more of the drug's intended effects over time so that an increased dose may be required to maintain the same physiological effects.
Physical dependence is a condition manifested by withdrawal symptoms when a drug is abruptly terminated or reduced in dose.
Addiction, in contrast, is a condition resulting in "impaired control over drug use, compulsive use, continued use despite harm, and craving."
While most individuals receiving opioid therapy do develop physical dependence, many studies confirm that patients treated with narcotics rarely become addicts.
The therapeutic approach believes the number of pills consumed is not an appropriate measure. Doctors must be allowed to trust the patient's reporting of pain and individualize the patient’s treatment. Law enforcement, on the hand, has moved to the view that patients complaining of pain who need large volumes of medication are likely addicts or diverters and, therefore, prescribing to them is not a legitimate medical purpose.
One last link for now: Dr. Frank Fisher (a doctor who was prosecuted and acquitted) on The Criminalization of Pain Management.
Next Tuesday, Kerlikowske is scheduled to release a "national action plan" to address the prescription drug abuse epidemic. Hope and change? Not where the War on Drugs is concerned.